SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Transgenomics (TBIO)
TBIO 0.05000.0%Jan 9 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: jmartin1641/28/2013 5:29:16 PM
   of 17
 
January 28, 2013

"Transgenomic, Inc. today announced it has completed the requirements for CE IVD and significantly expanded distribution of its Scan SURVEYOR kit to detect K-RAS mutations in most of the European Union. SURVEYOR Scan K-RAS kit is CE IVD kit Transgenomic family member to detect the mutations, which has a proprietary technology Surveyor endonuclease. Scanning Surveyor is a new approach to detect mutations, which has been shown to provide comparable sensitivity and greater specificity than other commercially available kits. The kit is CE IVD labeled available in the United Kingdom, Ireland, Austria, Belgium, Czech Republic, Denmark, France, Germany, Italy, Netherlands, Poland, Slovakia, Slovenia, Spain, Sweden and Switzerland. The company will also continue to offer the world a version only for research on the kit."

"Craig Tuttle, Transgenomic CEO, said: ‘The completion of the CE IVD significantly expands the market for kits K-RAS, and given our strong presence in molecular diagnostics laboratories in Europe, we are optimistic about their reception in the business sector. The combination of the earth with the WAVE HS platform provides highly sensitive, easy to use and cost effective way to measure somatic mutations not only in the K-RAS genes, but they soon BRAF, PIK3CA, EGFR, p53 and a series other genes involved in the ability to offer a family of CE IVD mutation detection kits for diagnostic use of our WAVE HS and other platforms commonly used in molecular diagnostic laboratories is a significant competitive advantage. In short, our K RAS-EC IVD kit is designed to be the first in a line of kits and options for an automated system Transgenomic."

http://pupurafakazazim.com/transgenomic-surveyor-extends-the-distribution-of-k-ras-mutation-detection-kit-scanning-ce-ivd/
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext